Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder

The postsynaptic density (PSD) contains a complex set of proteins of known relevance to neuropsychiatric disorders such as schizophrenia and bipolar disorder. We enriched for this anatomical structure in the anterior cingulate cortex of 16 bipolar disorder samples and 20 controls from the Stanley Medical Research Institute. Unbiased shotgun proteomics incorporating label-free quantitation was used to identify differentially expressed proteins. Quantitative investigation of the PSD identified 2033 proteins, among which 288 were found to be differentially expressed. Validation of expression changes of DNM1, DTNA, NDUFV2, SEPT11 and SSBP was performed by western blotting. Bioinformatics analysis of the differentially expressed proteins implicated metabolic pathways including mitochondrial function, the tricarboxylic acid cycle, oxidative phosphorylation, protein translation and calcium signaling. The data implicate PSD-associated proteins, and specifically mitochondrial function in bipolar disorder. They relate synaptic function in bipolar disorder and the energy pathways that underpin it. Overall, our findings add to a growing literature linking the PSD and mitochondrial function in psychiatric disorders generally, and suggest that mitochondrial function associated with the PSD is particularly important in bipolar disorder.

[1]  Daniel L. Koller,et al.  Identification of pathways for bipolar disorder: a meta-analysis. , 2014, JAMA psychiatry.

[2]  S Purcell,et al.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.

[3]  Stephan Heckers,et al.  Molecular evidence for mitochondrial dysfunction in bipolar disorder. , 2004, Archives of general psychiatry.

[4]  D. Luckenbaugh,et al.  The effects of chronic treatment with mood stabilizers on the rat hippocampal post‐synaptic density proteome , 2011, Journal of neurochemistry.

[5]  M. Vawter,et al.  The somatic common deletion in mitochondrial DNA is decreased in schizophrenia , 2014, Schizophrenia Research.

[6]  Laura J. Scott,et al.  Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways , 2015, Nature Neuroscience.

[7]  Ruben C. Gur,et al.  Cognitive and neural strategies during control of the anterior cingulate cortex by fMRI neurofeedback in patients with schizophrenia , 2015, Front. Behav. Neurosci..

[8]  A. West,et al.  Calcium regulation of neuronal gene expression , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Cagney,et al.  Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression , 2009, Molecular Psychiatry.

[10]  S. Grant,et al.  Comparative Study of Human and Mouse Postsynaptic Proteomes Finds High Compositional Conservation and Abundance Differences for Key Synaptic Proteins , 2012, PloS one.

[11]  K. Hashimoto,et al.  Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders. , 2015, Current molecular medicine.

[12]  M. Owen,et al.  Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice , 2014, Genome Medicine.

[13]  J. Rapoport,et al.  Increased abundance of translation machinery in stem cell–derived neural progenitor cells from four schizophrenia patients , 2015, Translational Psychiatry.

[14]  M. Mann,et al.  Quantitative, high-resolution proteomics for data-driven systems biology. , 2011, Annual review of biochemistry.

[15]  H. Sauer,et al.  Prefrontal gyrification in psychotic bipolar I disorder vs. schizophrenia. , 2015, Journal of affective disorders.

[16]  V. Haroutunian,et al.  Evidence for Abnormal Forward Trafficking of AMPA Receptors in Frontal Cortex of Elderly Patients with Schizophrenia , 2010, Neuropsychopharmacology.

[17]  Peilin Jia,et al.  Transcriptome Sequencing and Genome-wide Association Analyses Reveal Lysosomal Function and Actin Cytoskeleton Remodeling in Schizophrenia and Bipolar Disorder , 2014, Molecular Psychiatry.

[18]  C. Tomasetti,et al.  The emerging role of dopamine–glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment , 2014, Journal of psychopharmacology.

[19]  M. Casanova,et al.  Proteomic Analysis of Rat Prefrontal Cortex after Chronic Lithium Treatment , 2012 .

[20]  M. Mann,et al.  Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. , 2010, Immunity.

[21]  Kazuya Iwamoto,et al.  Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. , 2005, Human molecular genetics.

[22]  S. Kose,et al.  Correlations between amygdala volumes and serum levels of BDNF and NGF as a neurobiological markerin adolescents with bipolar disorder. , 2015, Journal of affective disorders.

[23]  P Dicker,et al.  Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia , 2014, Molecular Psychiatry.

[24]  C. Konradi,et al.  Mitochondria, oligodendrocytes and inflammation in bipolar disorder: Evidence from transcriptome studies points to intriguing parallels with multiple sclerosis , 2012, Neurobiology of Disease.

[25]  K. Davis,et al.  Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia , 2005, Synapse.

[26]  D. Kovar,et al.  JCB_201502062 1..9 , 2015 .

[27]  Richard D Emes,et al.  Synaptic scaffold evolution generated components of vertebrate cognitive complexity , 2012, Nature Neuroscience.

[28]  F. McMahon,et al.  An Integrative Genomic Study Implicates the Postsynaptic Density in the Pathogenesis of Bipolar Disorder , 2016, Neuropsychopharmacology.

[29]  J. Kennedy,et al.  Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder. , 2008, Bipolar disorders.

[30]  Vahram Haroutunian,et al.  Abnormal Activity of the MAPK- and cAMP-Associated Signaling Pathways in Frontal Cortical Areas in Postmortem Brain in Schizophrenia , 2012, Neuropsychopharmacology.

[31]  A. Carvalho,et al.  Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications , 2016, Neuroscience & Biobehavioral Reviews.

[32]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[33]  P. Baldi,et al.  Mitochondrial Mutations in Subjects with Psychiatric Disorders , 2015, PloS one.

[34]  E. Spiliotis,et al.  Septin functions in organ system physiology and pathology , 2013, Biological chemistry.

[35]  W. Qin,et al.  Altered functional connectivity of the cingulate subregions in schizophrenia , 2015, Translational Psychiatry.

[36]  M. Mattson,et al.  Mitochondria in Neuroplasticity and Neurological Disorders , 2008, Neuron.

[37]  G. Cagney,et al.  Reduced protein synthesis in schizophrenia patient-derived olfactory cells , 2015, Translational Psychiatry.

[38]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[39]  Eric S. Lander,et al.  A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.

[40]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[41]  R. Shelton,et al.  Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development , 2013, The Australian and New Zealand journal of psychiatry.

[42]  S. Grant.  Synaptopathies: diseases of the synaptome , 2012, Current Opinion in Neurobiology.

[43]  Yasunori Hayashi,et al.  The Importance of Dendritic Mitochondria in the Morphogenesis and Plasticity of Spines and Synapses , 2004, Cell.

[44]  M. Dunn,et al.  The Neuroproteomics of Schizophrenia , 2011, Biological Psychiatry.

[45]  M. Krams,et al.  Impaired mitochondrial function in psychiatric disorders , 2012, Nature Reviews Neuroscience.

[46]  M. Gill,et al.  Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders , 2014, Molecular Psychiatry.

[47]  V. Haroutunian,et al.  Expression of the NR2B‐NMDA receptor subunit and its Tbr‐1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia , 2010, Synapse.

[48]  S. Grant,et al.  Characterization of the proteome, diseases and evolution of the human postsynaptic density , 2011, Nature Neuroscience.

[49]  M. Casanova,et al.  Proteomic analysis of rat prefrontal cortex after chronic valproate treatment , 2014, Journal of neuroscience research.

[50]  J. Meador-Woodruff,et al.  Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder , 2004, Neuropsychopharmacology.

[51]  Ò. Miró,et al.  Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. , 1999, Carcinogenesis.

[52]  A. Fagan,et al.  Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder , 2008, Molecular Psychiatry.

[53]  P. Fox,et al.  Identification of a common neurobiological substrate for mental illness. , 2015, JAMA psychiatry.

[54]  H. Werner,et al.  The septin cytoskeleton in myelinating glia , 2009, Molecular and Cellular Neuroscience.

[55]  K. Davis,et al.  Mitochondrial enzymes in schizophrenia , 2007, Journal of Molecular Neuroscience.

[56]  David A. Lewis,et al.  Altered Cortical CDC42 Signaling Pathways in Schizophrenia: Implications for Dendritic Spine Deficits , 2010, Biological Psychiatry.

[57]  R. Myers,et al.  Mitochondrial involvement in psychiatric disorders , 2008, Annals of medicine.

[58]  T. Hashimoto,et al.  Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia , 2006, Molecular Psychiatry.

[59]  S. Grant,et al.  Human post-mortem synapse proteome integrity screening for proteomic studies of postsynaptic complexes , 2014, Molecular Brain.

[60]  R. Myers,et al.  Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders , 2006, Molecular Psychiatry.

[61]  D. Cotter,et al.  2‐D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease , 2009, Proteomics.

[62]  P. Callaerts,et al.  A network of synaptic genes associated with schizophrenia and bipolar disorder , 2016, Schizophrenia Research.

[63]  P. Renshaw,et al.  Regional cerebral cortical thinning in bipolar disorder. , 2006, Bipolar disorders.

[64]  Stephen J. Callister,et al.  Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. , 2006, Journal of proteome research.

[65]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[66]  N. Kato,et al.  Mitochondrial dysfunction in bipolar disorder. , 2000, Bipolar disorders.

[67]  R. Ross,et al.  Brain pH has a significant impact on human postmortem hippocampal gene expression profiles , 2006, Brain Research.

[68]  Lin He,et al.  A comparative proteomics analysis of rat mitochondria from the cerebral cortex and hippocampus in response to antipsychotic medications. , 2009, Journal of proteome research.

[69]  Jane A English,et al.  Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. , 2011, Archives of general psychiatry.

[70]  G. Lynch,et al.  Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia , 2015, Molecular Neuropsychiatry.

[71]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[72]  Angel Pizarro,et al.  The Post-Synaptic Density of Human Postmortem Brain Tissues: An Experimental Study Paradigm for Neuropsychiatric Illnesses , 2009, PloS one.